Conversely, a few studies documented an increased level of intra-tumoral T-reg cells in patients with B-cell lymphomas, leading, in some cases, to the inhibition of intralesional CD8+ T-cells [20,32]. The gene discussed is CD8A; the disease is B-cell non-Hodgkin lymphoma.